How Rising Drug Prices Affect Your Insurance

The cost of prescription drugs has been increasing over the past years across the United States. Its impact steadily affects all healthcare industry sectors, especially health insurance policies. Employers are finding it difficult to get the value of what they insure, therefore passing the cost of drugs to employees. In a recent study by AHIP, over…

ByEvans JamesSeptember 26, 2024

THOUGHTSPOT

What are the Top Locations for Locum Tenens Cardiology Jobs in the United States?

Are you a cardiologist looking for a change? Locum tenens cardiology jobs offer the chance to broaden your experience, work in various settings, and enjoy flexibility in your career. Florida is a top location for locum tenens cardiology jobs due to its large population and high demand for healthcare services. Moving between assignments allows you…

ByEvans JamesAugust 16, 2024

VIEWPOINTS

Establishing Safe Treatment: Dr. Robert Rifikin from Rocky Mountain Cancer Centers in Conversation with PharmaShots

Shots: There is an average lifetime risk of getting multiple myeloma of about 1 in 103 men and 1 in 131 women in the United States Treatment of multiple myeloma using fourth-line therapy like teclistamab can induce issues like cytokine release syndrome (CRS) and neurotoxicity Today, at PharmaShots we have Dr. Robert Rifikin from Rocky…

BySaurabh ChaubeyAugust 5, 2024

VIEWPOINTS

CSAP Management: Uwe P Tigör from Auxilius Pharma in Conversation with PharmaShots

Shots:Chronic Stable Angina Pectoris (CSAP) affects over 11M patients in the US. Often considered as the first manifestation of an underlying coronary disease, there is a dearth of new-age innovative anti-anginal drugs Today at PharmaShots we have Uwe P Tigör, Co-founder and Chief Medical Officer at Auxilius Pharma, shedding light on the positive results…

BySaurabh ChaubeyJune 5, 2024

INSIGHTS+

J.P. Morgan Special: Dealmaker of the Year 2023 (Part 02)

Shots: In the next installment of Dealmaker 2023, we bring an informative report on the Top M&A based on the Deal Value The report revolves around Pfizer, which signed 16 collaborations comprising acquisitions, contract services, development & commercialization, license, R&D, and product purchases that have summed to a total of $63.23B Propelled by the invaluable…

BySenior EditorJanuary 15, 2024

NEWS

Boan Biotech Highlights Clinical Updates for BA6101 (biosimilar, Prolia) and BA1102 (biosimilar, Xgeva) to Treat Various Indications

Shots:The company has completed patient enrolment in P-III trial which evaluates the safety, efficacy, PK & immunogenicity of BA6101 & BA1102 vs reference drugs (Prolia & Xgeva) for the treatment of various indication across Europe, United States & Japan Boan also conducted a meeting in Germany to highlight the PK results from the…

ByDipanshu DixitJanuary 15, 2024

INSIGHTS+

J.P. Morgan Special: Deal Maker of the Year 2023 (Part 01)

Shots:As the year began, PharmaShots was busy analyzing the deals throughout 2023 to prepare a special report, viz. JP Morgan 2024 Special: Deal Maker of the Year 2023 (Part 01)The report features Roche, that signed 26 collaborations comprising acquisitions, contract services, development & commercialization, license, R&D, and product purchasesPropelled by the invaluable…

BySenior EditorJanuary 4, 2024

VIEWPOINTS

Kylen Cieslak and Robert Ley Discuss the Expansion of Thermo Fisher Scientific’s Services Central in the US & EU

Shots: Kylen Cieslak, Senior Manager, Service Marketing, Thermo Fisher Scientific, and Robert Ley, Senior Strategic Product Manager, Thermo Fisher Scientific in a stirring conversation with PharmaShots Kylen and Robert highlighted the recent expansion of Thermo Fisher Scientific’s Services Central in the United States and Europe Services Central is an online platform intended to provide 24/7…

BySaurabh ChaubeyDecember 7, 2023

VIEWPOINTS

Sujay Jadhav converses about VeraSite, a recently launched subscription-based tool for clinical trial site selection

Shots: In an insightful interview with PharmaShots, Sujay Jadhav, CEO of Verana Health, discusses VeraSite, a recently launched subscription-based tool for clinical trial site selection To gather real-world data, Verana Health leverages the VeraQ population health data engine and transforms the structured and unstructured data into curated disease-specific modules called QData Currently available in the…

BySaurabh ChaubeyOctober 17, 2023

How Rising Drug Prices Affect Your Insurance

What are the Top Locations for Locum Tenens Cardiology Jobs in the United States?

Establishing Safe Treatment: Dr. Robert Rifikin from Rocky Mountain Cancer Centers in Conversation with PharmaShots

CSAP Management: Uwe P Tigör from Auxilius Pharma in Conversation with PharmaShots

J.P. Morgan Special: Dealmaker of the Year 2023 (Part 02)

Boan Biotech Highlights Clinical Updates for BA6101 (biosimilar, Prolia) and BA1102 (biosimilar, Xgeva) to Treat Various Indications

J.P. Morgan Special: Deal Maker of the Year 2023 (Part 01)

Kylen Cieslak and Robert Ley Discuss the Expansion of Thermo Fisher Scientific’s Services Central in the US & EU

Sujay Jadhav converses about VeraSite, a recently launched subscription-based tool for clinical trial site selection

Contact US

OUR INFORMATION

FOLLOW US